ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000211.1|Chrysomycin_1 # 1 # 561 # -1 # ID=1_1;partial=00;start_type=TTG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.658	BGC0000211.1|Chrysomycin_1 	1	561	-	Loose	400	25.0238	vanR gene in vanD cluster	27.5	3002923	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	TTGACTGTCCATCAGCTGCGCAGCGTCTCCCGATCCGAGCACAACCTTCTGGATGAGTCGTGGGTCACATTGGGCAGGAGCAACCGCCTCGAAGAGTTGCAAGGGGGAAATATGAGATTCAGCCGTTCCGTCCTGGCTGCCTCCGCCGTAGCGGCCCTGGCCATGGGGGCCACGACCGCCCTGGCGGCGCCGGCCTCCGCCGCGCCCAACACCACCCCGCAGAAGGTCTGCGGAAGCGGCTACAAGACCGTGAACTCGGTGCCCGTCGGATCGCAGGGGACCGTCTACCTGACGTACAACTCGACCAACGGCAAGAACTGCGTCGCGACCATCCGCACCAACCCGGGCACCGCCCGGGACATGTCCGCGTGGATCTACGTCCCCGACACCGACGCGTACGACCAGGACTACGGGACGTACACGTCGTACGCGGGACCGACCTACGTCTACGGCAAGGCCCACTGCGTCGACTGGGGCGGCAGCATCGGCAACGTGTACGTGGAGGTGTACGGCTCCAACTGTGCCGCGCTGAGGGAGCACCGGGTCACCTACACCCGCTGA	MTVHQLRSVSRSEHNLLDESWVTLGRSNRLEELQGGNMRFSRSVLAASAVAALAMGATTALAAPASAAPNTTPQKVCGSGYKTVNSVPVGSQGTVYLTYNSTNGKNCVATIRTNPGTARDMSAWIYVPDTDAYDQDYGTYTSYAGPTYVYGKAHCVDWGGSIGNVYVEVYGSNCAALREHRVTYTR	MNEKILVVDDEKELADLVEVYLKNDGYTVYKFYNGRDALNCIESVELDLAILDIMLPDIDGFQICQKIREKFYFPVIMLTAKVEDGDKIMGLSVADDYITKPFNPLEVVARVKAQLRQYMRYKQPCIKQEAERTEYDIRGMTISKSSHKCILFGKEIQLTPTEFSILWYLCERQGTVVSTEELFEAVWGERYFDSNNTVMAHIGRLREKMKEPSRNPKFIKTVWGVGYTIEK	80.17	gnl|BL_ORD_ID|1052|hsp_num:0	1004			81	186	vancomycin; teicoplanin
BGC0000211.1|Chrysomycin_2 # 893 # 1678 # 1 # ID=1_2;partial=00;start_type=TTG;rbs_motif=AGGAG;rbs_spacer=5bp;gc_cont=0.705	BGC0000211.1|Chrysomycin_2 	893	1678	+	Loose	475	24.6386	Bla2	31.82	3004189	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	subclass B1 Bacillus anthracis Bla beta-lactamase	TTGGCGAACGGTGCCGGAAAGACCGCTCTCATCACCGGAGCGACCAGTGGCATCGGCCTGGCCGTCGCACACCGGCTGGCCGAGTCCGGCTTCCGCGTCTTCCTGTGCGCCCGTGGCGCGGACGCCGTGAAGCGGACGGCCGGGCAGCTCCGGGCCGCGGGCCACGAAGCGGACGGCGTCGCCTGCGACGTCCGCTCGGCGGAGCGGATACGGGCGATGGTGACCGAGGCGGCCGAGCGCTACGGCAGCATCGACGTCCTCGTCAACAACGCGGGCACCGGTGGCGGCGGCGTCACCGCGGACCTCACCGACGAGGCGTGGGCCGACGTCATCGACACGAACCTCAACAGCGTCTTCCACGTCACGCGCGACGTGCTCTCGATGGGCCGGATGCGCGACAAGAGCTGGGGACGCATCGTCAACATCGCCTCGACCGCGGGGAAGCAGGGCGTGGTCCTCGCCGCCCCGTACTCGGCGTCCAAGCACGGGGTCGTCGGATTCACCAAGTCCCTCGGGAACGAGCTGGCGAAGACCGGCATCACCGTGAACGCGGTCTGCCCGGGATACGTGGAGACGCCGATGGCGGAGCGTGTGCGCAGCGGCTACGCCCGGGCGTGGGAGACGACCGAGGAGGACATCCTCCAGCGGTTCGAGGCGAAGATCCCGCTGGGCCGCTACTCGACCGTCACCGAGGTGGCGGGCATGGTCGGCTACCTCGTCAGCGACACCGCCGCCTCGGTGACCTCGCAGGCCATCAACGTGTGCGGCGGCCTCGGCAACTTCTGA	MANGAGKTALITGATSGIGLAVAHRLAESGFRVFLCARGADAVKRTAGQLRAAGHEADGVACDVRSAERIRAMVTEAAERYGSIDVLVNNAGTGGGGVTADLTDEAWADVIDTNLNSVFHVTRDVLSMGRMRDKSWGRIVNIASTAGKQGVVLAAPYSASKHGVVGFTKSLGNELAKTGITVNAVCPGYVETPMAERVRSGYARAWETTEEDILQRFEAKIPLGRYSTVTEVAGMVGYLVSDTAASVTSQAINVCGGLGNF	MKNTLLKLGVCVSLLGITPFVSTISSVQAERKVEHKVIKNETGTISISQLNKNVWVHTELGCFNGEAVPSNGLILNTSKGLVLVDSSWDDKLTKELIEMAEKKFKKSVTDVIITHAHADRIGGIKTLKERGIKAHSTTLTAELAKKNGYEEPLGDLQAITKLKFGNMKVETFYPGKGHTEDNIVVWLPQYNMLVGGCLVKSASAKDLGNITDAYVNEWSTSIENVLKRYENINFVVPGHGEVGDKGLLLHTLDLLK	101.95	gnl|BL_ORD_ID|2423|hsp_num:0	2836			624	690	
BGC0000211.1|Chrysomycin_5 # 2794 # 4335 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.752	BGC0000211.1|Chrysomycin_5 	2794	4335	+	Loose	600	304.679	Streptomyces venezuelae rox	43.21	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGACGGGGACGGGCACCGGCCCCGGGCCCGGTGCGGCGGCGCCGGACGCACGGCTGGACGCGCCGGTCGTCGTGGCCGGCGCGGGACCCACCGGACTGATGCTGGCCGGTGAACTCCGCCTCGGCGGCGTGGAGGTGATCGTCCTCGACCGGCTGACCGAGCCGGTCACCGAGTCCCGCGGACTCGGCTTCACCGCCCGGGCCACCGAGGTCTTCGACCAGCGGGGCCTGCTGGACCGCTTCGCGAACCCCGAGATCAGCCCACGGGGCCACTTCGGCGGCATCCCGATGGACTACGACGTCCTGCCCGGCGGGCACTTCGGCGTACGCAACGTCGAACAGACCGAGACCGAGCGCGTGTTGAGAGAGTGGGCCACCGGACTCGGGGCCGGTGTCCGGCCCGGCCACGAGGTCACCGGCGTACGGCAGTCCGGGGAGCGGGTCGAGGTCGAGGTGTCCGGCCCCCGGGGCGAGGAGGTGCTGCGCTGCTCCTACCTGGTCGGCGCGGACGGCGGGCGCAGCACCGTGCGGCGGGCCGCGGGCTTCGACTTCCCCGGGCACGACGCGACCTGCGAGATGTTCCTGGCCGACGTCGCGGGCGTCGGCATCCGCCCGCGGTTCCTCGGTGAACGGGTTCCCGGCGGCATGGTGATGGCCGCCCGGCTGAGCGACGACGTGGACCGCGTCATCGTCTGCGAACGCGGTACCGCGCCCGAGGAGCGCACCGCGCCGCCCGCCTTCCAGGAGATCGCCGGTGCGTGGCGGCGGCTCACCGGTGAGGACATAAGCCACGGCGAGGCCCGCTGGACCAGTTCCTTCACCGACGCCGCGCGGCTCGTCACCGAGTACCGCCGCGGACGCGTGTTCCTGGCCGGGGACGCCGCCCACATCCATCTGCCGGCGAGCGGCCAGGGCCTCAGCGTCGGTGTGCAGGACGCGGTGAACCTGGGCTGGAAGCTCGCGGCCGTCGTCGGCGGCCACAGCGACGAGAGCCTGCTCGACACCTACCACCGGGAACGCCACCCCGTGGGCGAGCGCGTCCTGACCAACACCCGGGCCCAGGGCCTCCTCTACCTCGGCGGCAGCGAGGTGGAACCGCTGCGCGCGGTGCTCGGCGAACTGCTGGACGACCCCGGGGTGGCCCGCCGTCTGGCCGGGATGGTCAGCGGCCTCGACATCCGCTGTCCCGTCGGCCCCGGCACCCACCCCCTGCTCGGGCTGCGGATGCCCCCCTGCGACCTGCTCGTCGGCGCGGACGCCACCACCTCGGCGTGTCTGCTGCGTGCCGGGCGGGGCGTACTCCTCCAGCTCGACGACGACCCCGGCCCGGCCCGGACCGCCGCACCGTGGGCGGGCCGCGTCGACGTCGTGCAGGCGGTCTGCGCCGACGAACGACTCGCCGGTACACGTGCCGTACTGCTGCGCCCCGACGGCCACATCGCCTGGGCGGCGCCCGACGGAGGGGACCTGGCCGAAGCGCTCGGCACCTGGTTCGGGGCCGCCGGCCGCGTCCGGCGGGCGGTGACCGCGGCACACCGGTGA	MTGTGTGPGPGAAAPDARLDAPVVVAGAGPTGLMLAGELRLGGVEVIVLDRLTEPVTESRGLGFTARATEVFDQRGLLDRFANPEISPRGHFGGIPMDYDVLPGGHFGVRNVEQTETERVLREWATGLGAGVRPGHEVTGVRQSGERVEVEVSGPRGEEVLRCSYLVGADGGRSTVRRAAGFDFPGHDATCEMFLADVAGVGIRPRFLGERVPGGMVMAARLSDDVDRVIVCERGTAPEERTAPPAFQEIAGAWRRLTGEDISHGEARWTSSFTDAARLVTEYRRGRVFLAGDAAHIHLPASGQGLSVGVQDAVNLGWKLAAVVGGHSDESLLDTYHRERHPVGERVLTNTRAQGLLYLGGSEVEPLRAVLGELLDDPGVARRLAGMVSGLDIRCPVGPGTHPLLGLRMPPCDLLVGADATTSACLLRAGRGVLLQLDDDPGPARTAAPWAGRVDVVQAVCADERLAGTRAVLLRPDGHIAWAAPDGGDLAEALGTWFGAAGRVRRAVTAAHR	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	107.77	gnl|BL_ORD_ID|4833|hsp_num:0	5820			9	1419	rifampin; rifaximin; rifapentine
BGC0000211.1|Chrysomycin_8 # 5072 # 6016 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.716	BGC0000211.1|Chrysomycin_8 	5072	6016	+	Loose	600	28.1054	OprZ	43.75	3004142	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCCGGACCGAAGGTCCACGAAGCCGAGCACCACATCACCGTCGCCGCGTCCGCGAAGGCCGTCCACCAGCTTCTCGTCGAGGTGGAGAACTGGCCGCTGCTGTTCCCGCCGAGCGTGCACGTGGAACGCCTCGAACAGGACGGTGAGCACGAACGGATACGGATCTGGGCCACCGCCAACGGCGCGGCCAAGACCTGGACGTCCCGCAGGCGTATCGACGCCGCCGAAGGCCGGATCGAGTTCCGGCAGGAGGTGTCGAGCCCGCCGGTCGCCGCGATGGGCGGCACCTGGACCGTCGAGGCGGACGGCGAGGAGCGCTGCCGGGTGCGGCTGCTGCACGACTACCGTGCCGTCGACGACGACCCGGCCGCACTGGAGTGGATCGCCGCCGCCGTCGACCGCAACAGCCGGGCCGAACTGGACGCGCTGAAGACCCACGCGGAGGCGGCGGCCGACGGTTCGAGCCCGCTGTTCTCGTTCGAGGACAGCCGCCGGATCGCCGGACGCGCGCAGGACGTCTTCGACTTCGTCAACGAGGCGGACCTGTGGCCGCGGCGGCTGCCGCACGTCGCCCGGGTGCGGCTGGAGGACGAGGACGGACTGCAGCTGCTGGAGATGGACACCCACGCGCCCGACGGGTCGGTGCACACCACCACGTCGGTCCGCGTGTGCCTCGCCCCGCACCGCATCCACTACAAGCAGATCCAGGTCCCGGCCCTGATGTCGCTGCACACGGGGGAGTGGCGGTTCGAGGAGGACGCCGACGGCGTCCTGGCCACGTCCCGGCACACCGTCGCCGTCGACGAGTCCGCCGTCAAGGCGGTCCTCGGCGAGGACGCCACCCTTGAGGACGCCCGGGCCATGGTCCGCAAGGCCCTCGGCGCCAACAGCCTGAGCACCCTCGACCGGGCCAAGGCCCACGTCGAGGGCGGCGGTTCATGA	MSGPKVHEAEHHITVAASAKAVHQLLVEVENWPLLFPPSVHVERLEQDGEHERIRIWATANGAAKTWTSRRRIDAAEGRIEFRQEVSSPPVAAMGGTWTVEADGEERCRVRLLHDYRAVDDDPAALEWIAAAVDRNSRAELDALKTHAEAAADGSSPLFSFEDSRRIAGRAQDVFDFVNEADLWPRRLPHVARVRLEDEDGLQLLEMDTHAPDGSVHTTTSVRVCLAPHRIHYKQIQVPALMSLHTGEWRFEEDADGVLATSRHTVAVDESAVKAVLGEDATLEDARAMVRKALGANSLSTLDRAKAHVEGGGS	MKPVAMTLLALALSGCSLAPTHERPAAPVPAQYDTPAQPGQAAAPQDWRAYFNDPALQAWIAAALANNRDLRVAALRIEEARALYGVQQSERLPAIDASGEFSRGRATEPGQPRTPVSNRYRAAVGITAFELDFFGRVRSLSDAALARYLASEEAHRAATLALVAETATAYFNQRSLAEQLRLTDDTLALRETTLKLTQRRYDAGLETAIGLRTAQMLVESSRATRAELTREASLARHALGLLAGDFALPLGVDPTPLESQSLTPLAAGLPSELLTRRPDLRQAEQALRAANADIGAARAAFFPSVQLTTDIGTTADRFSDLFSGGTGGWSFAPRLTLPIFNAGRNRANLSLAETRKHIAVAQYEGSIQAAFRDVADALSARDALRDQIEAQRKVRDADRERQRLAERRYARGVANYLEMLEAQRSLFESEQEFIRLQQRRLVNAVDLYKALGGWDDGSSPAS	67.82	gnl|BL_ORD_ID|2408|hsp_num:0	2796			135	231	erythromycin; cefepime
BGC0000211.1|Chrysomycin_9 # 6048 # 7523 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.770	BGC0000211.1|Chrysomycin_9 	6048	7523	+	Loose	600	273.478	Streptomyces venezuelae rox	40.04	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGACGCCGCCGGACGCCACCGAACAGACGCGGGTGCTCGTGGTCGGTGCCGGCCCCGTGGGGCTGCTCCTCGCGGGCGACCTGCGGCGGTACGGAGCGGAGGTCGTCCTCGTCGACCGGCTCGCGCGGCCGATGACCGAGTCCCGGGCGTCGCAGCTCAACGCCCGCACCATGGAACTGCTCGACCAGCGCGGCCTGGTGGACGGGCTCGGCGGACCCCAGCCGGAGAGCGCCGGCCACTTCGGGGGCCTGCCCTTCGACGCGGCCGGCACGGCGAGCCGCTACGCGGGCAACTGGAAGGTCCCCCAGTTCCGCACCGAGGCGGCCCTGACCCGGTGGGCGCTCGCGGCCGGCGTCGACCTGCGCCGGGAGCACGAACTGTGCGAACTCCGCGTCACCGACGAGGCGGTGACCGCCGTCCTGCGGACCCCGACGGGCCCGCGCACCGTGCGCGCCGCGTACGTCGTCGGCTGCGACGGCGCCGGGAGCACCGTACGCGCCCTCGCCGGCTTCGAGCTCGCGGGCAACGACGCCGTACGGGAGCTGCTGCGCGCCGACATCCAGGGCGTACGGGTGCCCGACCACCGGTTCGAACGCCGTGCACGAGGCTTCGCCGCCTCCGCGCGGCGCCCCGACGGCGTCACCCGCGTGATGGTGCACGAGTCCGGCCGGCCCCCGGCCCGCCGCACCGGCCCCCCGCCCTTCGCCGAGGTCGTCCGCGCCTGGCGGACGGTCACCGGCGAGGACATCAGCGGCGCCGCACCGGTCTGGCTCGACTCCTTCGACGACGCCTGCACACAGGCCACCCGGTACCGGCGCGGCCGCGTGCTGCTCGCGGGCGACGCGGCCCACGTCCACATGCCCGTCGGGGGACAGGCGCTCAACCTCGGCCTGCAGGACGCGGCCAACCTCGGCTGGAAACTGGCCGCGAGCCTGCACGGCTGGGCGCCACCGGGCCTGCTCGACAGCTACCACGAGGAGCGGCACGCCGTCGGCGGACGGGTCCTGGACAACGTACGGGCGCAGGGACTGCTGCTGTTCGGCGGAGGTGAGGCCGACCCGGTGCGGGCGGTGTTCGGCGAACTGCTGGCCGAGACCGGCGCCGGGGACCTGCTGGCCCGCATGGTGAGCGGCCTCGACGTGCGCTACGACACGGGCCCCGGCCGGGCGCCGCTGCTGGGCGCGCGCATGCCCGACCTCGACCTGACCGTCGACGGCGGTCCCACGAGGGTGGCCCGGCTGCTGCACGACGGGCACGGGGTCCTGCTCGACCTCACCGGGGACGGCGCCGGCGCCGCGCGCTTCCGCGCGGCGCTGCCCGCGGGGGCCCGCCAGGTGCGCGTCGTCACCGCGCGCCCCGTGCGGGAGCACCCCGACGGAGCGGTGTTCCTGCTGCGGCCCGACGGACACGTCGTGTGGACCGACCGGGTGCGGGCCCCCCTGGCAGGGGCGGCGCGGCGGTGGTTCGGCGTCTGA	MTPPDATEQTRVLVVGAGPVGLLLAGDLRRYGAEVVLVDRLARPMTESRASQLNARTMELLDQRGLVDGLGGPQPESAGHFGGLPFDAAGTASRYAGNWKVPQFRTEAALTRWALAAGVDLRREHELCELRVTDEAVTAVLRTPTGPRTVRAAYVVGCDGAGSTVRALAGFELAGNDAVRELLRADIQGVRVPDHRFERRARGFAASARRPDGVTRVMVHESGRPPARRTGPPPFAEVVRAWRTVTGEDISGAAPVWLDSFDDACTQATRYRRGRVLLAGDAAHVHMPVGGQALNLGLQDAANLGWKLAASLHGWAPPGLLDSYHEERHAVGGRVLDNVRAQGLLLFGGGEADPVRAVFGELLAETGAGDLLARMVSGLDVRYDTGPGRAPLLGARMPDLDLTVDGGPTRVARLLHDGHGVLLDLTGDGAGAARFRAALPAGARQVRVVTARPVREHPDGAVFLLRPDGHVVWTDRVRAPLAGAARRWFGV	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	103.15	gnl|BL_ORD_ID|4833|hsp_num:0	5820			9	1413	rifampin; rifaximin; rifapentine
BGC0000211.1|Chrysomycin_10 # 7586 # 8854 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.708	BGC0000211.1|Chrysomycin_10 	7586	8854	+	Loose	750	198.364	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	34.98	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGAGGCGGCGAGTTGTCATCACCGGCATAGGAGTGCTGGCACCGGGAGGTGTCGGCACCAAGAATTTCTGGTCGCTGATCAGCGAGGGACGCACGGCGACGCGCACCCTGACGCGTTTCGACCCCACCCCGTACCGCTCACGGGTCGCGGCCGAGGTCGACTTCCGCCCGCAGGAGCACGGCCTGCGGGCCCAGGAGATACGCCGGATGGACCGCGCGGCGCAGTTCGCGGTGGTCGCCACCCGCGAGGCGGCGGCCGACAGCGGACTCGAACTGTCCGAACTGGACCCCTGCCGCACCGGCGTGACCATCGGCAGCGCCGTCGGGGCCACCACCAGCCTGGAGGACGAGTACCGGGTGGTGAGCGACGACGGCGCGGCCCGTCTCGTCGACCACGCGTACGCCACCCCGCATCTGTACGACTACCTCGTGCCGAGCTCGTTCGCCGCCGAGGTGGCGTGGTCGCTCGGTGCCGAGGGGCCGAGCACCGTGGTGTCCACCGGCTGCACCTCGGGCATCGACGCGGTGGCGCACGCCGTCGAGCTGATCCGCGAGGGCAGCGCCGACGTGATGATCACGGGCGCGACCGAGGCCCCGCTGTCCCCGATCACCGTCGCCTGCTTCGACGCGATCAAGGCGACGACCGTGCACAACGACGACCCCGAACACGCCTCCAGGCCCTACGACAGCACCCGCAACGGCTTCGTCCTCGGCGAGGGCGCGGCGGGATTCGTACTGGAGGAGTACGAGAGCGCGAGGCGGCGTGGCGCCACCGTCTACGCGGAGATCGTCGGCTACGCCACCCGCAGCAACGCCTACCACATGACCGGACTGCGCCCGGACGGCGCGGAGATGGCCGATGCCATCACCGCGGCGCTCGACGAGGCCCGCCTCGACCCGGGCGACCTCGACTACGTCAACGCCCACGGGTCCGGCACCAAGCAGAACGACCGCCACGAGACCGCCGCGTTCAAGCGCAGCCTCGGCGAGCACGCCTACCGCCTGCCGGTGAGCTCCATCAAGTCGATGGTGGGCCACTCGCTCGGGGCGATCGGGTCGATCGAGATCGCCGCGTCCGTGCTGGCCGTCAAGGAGAACGTCGTGCCGCCCACCGCCAACCTGCACCGGCAGGATCCCGAACTCGACCTGGACTACGTGCCGTTGACCGCGCGCGACTGGAAGACCGACCGGGTGCTCACCGTGGGCAGCGGGTTCGGCGGTTTCCAGAGCGCGATGGTGCTGGCACGGCCCGGAAGGAGCACCGCATGA	MRRRVVITGIGVLAPGGVGTKNFWSLISEGRTATRTLTRFDPTPYRSRVAAEVDFRPQEHGLRAQEIRRMDRAAQFAVVATREAAADSGLELSELDPCRTGVTIGSAVGATTSLEDEYRVVSDDGAARLVDHAYATPHLYDYLVPSSFAAEVAWSLGAEGPSTVVSTGCTSGIDAVAHAVELIREGSADVMITGATEAPLSPITVACFDAIKATTVHNDDPEHASRPYDSTRNGFVLGEGAAGFVLEEYESARRRGATVYAEIVGYATRSNAYHMTGLRPDGAEMADAITAALDEARLDPGDLDYVNAHGSGTKQNDRHETAAFKRSLGEHAYRLPVSSIKSMVGHSLGAIGSIEIAASVLAVKENVVPPTANLHRQDPELDLDYVPLTARDWKTDRVLTVGSGFGGFQSAMVLARPGRSTA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	101.44	gnl|BL_ORD_ID|1968|hsp_num:0	1943			303	1245	isoniazid
BGC0000211.1|Chrysomycin_11 # 8851 # 10059 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=6bp;gc_cont=0.735	BGC0000211.1|Chrysomycin_11 	8851	10059	+	Loose	750	29.6462	mefC	31.08	3003745	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACGGTCGTCGCGGTCACCGGCATCGGTGCCATCGCGCCCAACGGACAGGGCACCGAGGCGTACTGGAAGTCCACCGTCGAAGGGATCGGCGGTATCGCCGAGATCAGCCGGTTCGACGCCTCCGCCTACCCGTCGAAGCTGGCCGGCGAGGTGGTCTTCGACGCCCCCGCGCACCTGCCCAGCAGGCTGATCCCGGCGACCGACCACATGACGCGGCTCGCCCTCGCCGCCGCGGACTGGGCGCTCGAGGACGCGGCGGTACGGCCCGCGGACCTGCCCGACTTCAGCACCGGCGTCATCACCGCCGGTTCCGCCGGAGGCTTCGAACTCGGCCAGCGCGAGCTGGAGAACCTGTGGAGCAAGGGCTCCAAGTACGTCAGCGTGTACCAGTCCTACGCCTGGTTCTACGCCGTCAACTCCGGTCAGATCTCCATCCGGCACGGGATGCGCGGACCCAGCGGCGTGGTCGTCGGCGACCACGCGGGCGGCCTCGACGCGATCGCCCAGTCCCGGCGCCAGATCCGCAAGGGCACCAGCCTGATCGTCTCCGGCGCCGTGGACGGCTCCCTGTGCCCCTGGGGCTGGGTCGCGCAGATGACGGACCCCCGGATGAGTTCCGCCGCCGACCCACGGGAGGCGTACCTGCCCTTCGACCCGAGGGCCGGCGGGTACGTGCCGGGCGAGGGCGGCGCGCTGCTCGTGATGGAGGACCTGGAGCACGCCCGCGGGCGCGGAGCGCGGATCTACGGCGAGGTCGCCGGATACGGCGCGACCACCGACCCCAGGCCGGGCAGTTCACGCGAACCCGGTCTGCGTCGCGCGCTCACGCTCGCGCTCGACGACGCGGGGGCCGCCCCGGAGGACGTCGACGTCGTCTTCGCGGACGCGGCCGCCGTGCCCGAACTCGACCGCGTCGAGGTCGAGGCGATCAACCGTGTCTTCGGCGCCGGCCGGGTGCCGGTCACCGCGCCGAAGACGATGACAGGCAGGCCGGCGGCCGGGACGGCGGCGCTGGACGTCGCGGGGGCGCTGCTGGCGATCCGGGACGGCGTGATCCCGCCGACCGTGAACGTCACGCGCGCCCCCGCCTACGACATCGACCTGGTCACCGGGAGCGCGCGCCGGGCTCCCGTGCGGACCGCGGTCGTACTGGCCAGGGGCCACGGCGGCTTCAACTCCGCGGTCGTGGTGCGCGAGGCGCGATGA	MTVVAVTGIGAIAPNGQGTEAYWKSTVEGIGGIAEISRFDASAYPSKLAGEVVFDAPAHLPSRLIPATDHMTRLALAAADWALEDAAVRPADLPDFSTGVITAGSAGGFELGQRELENLWSKGSKYVSVYQSYAWFYAVNSGQISIRHGMRGPSGVVVGDHAGGLDAIAQSRRQIRKGTSLIVSGAVDGSLCPWGWVAQMTDPRMSSAADPREAYLPFDPRAGGYVPGEGGALLVMEDLEHARGRGARIYGEVAGYGATTDPRPGSSREPGLRRALTLALDDAGAAPEDVDVVFADAAAVPELDRVEVEAINRVFGAGRVPVTAPKTMTGRPAAGTAALDVAGALLAIRDGVIPPTVNVTRAPAYDIDLVTGSARRAPVRTAVVLARGHGGFNSAVVVREAR	MENRKWFKTYMFIWAGQFASMLTSYAVQFAIVIWLSLEYKSAEVLAYAGIAAMLPQALIGLIAGVYVDRLNRKYVMIFSDAFIALCALLLLVILQNENVNLIWIYILLGLRSVGNAFHAPALQAIAPLIVPQNELIKVAGINQVLHSVCRIGGPAIGTLAIAYLPISKVLYLDLIGALLAILSLVMVKIPNVVAKSKSSAHSIATEFSEGFQTVSKNKGLRYLFLYAMAITFVIMPAAIMFPLLTTGHFAGGKWEIGIVEVVWGGGMLIGGVILSIFKLKGSKVVAVNVMYVLLGLTFILSGVLPASWFVGFVMVTAIGGISLSVFNGCFTAIVQTEVSPEKLGRVFSLYYSLAVLPSVIGLLFTGLIAEVIGVNITFIISGCLAILVGILSFSTRNLMQLGKIKNI	98.77	gnl|BL_ORD_ID|2049|hsp_num:0	2262			387	609	
BGC0000211.1|Chrysomycin_13 # 10415 # 11599 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=6bp;gc_cont=0.706	BGC0000211.1|Chrysomycin_13 	10415	11599	+	Loose	1000	26.1794	MCR-7.1	25.86	3004517	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGACGACCAGCACCGTCCCCCGCAGCGACATCGACCCCTACAGCGACGCGTCGATCCTCTCCCCGTACGAGGACTACCGGCGGCTGCGCGACCTCGGACCCGTGGTGTGGCTGGAGTCCCACCAGGTCTTCGCGGTCGCCCGGTACCGGGAGGTCTACGACGCGCTGCACGACCACACGACGTTCTCGTCGGGCTCCGGCGTGGGACTGACCGAGACGCTCAACAAGGCGCAGAAGGGCAGCAGCTTCACCAGCGACCCGCCGTACCACGGCTACGTACGCGGGCTGGTGGCCCGGCACCTGAAGCCGAAGGCGCTGGAGCGGTTCCACGACTACATCGAGGGCTGGGCGAACCGGCTCGTCGACGAACTCATCGAGAAGGGCACGTTCGACGCGGTCACCGACTTCGCCCAGGCCTTCCCGCTGGCGGTCGTCCCCGACCTGCTCGGCTGGCCCGTCGAGGAGGGCAAGGAGCGGCTGCTGGAGTGGGCGACCGCCGGCTTCAACGCCTTCGGCCCCCTCAACGAGCGCACCATGTCCGGCTTCCCGCTGCTCAAGGAGATGTCCGAGTTCCTCCAGCGGATGTCGGTCCCCGGAAACCTGCGGCCGGGCAGCTGGGGCGCCGAACTCGTCAGCGACGCCAAGGAGGGCAGGATCGAGGAGTACCTGCTGCCGGGTCTGCTCGGGGACTTCCTCGCGCCCTCGATGGACACCTCCGTCAGCGCGCTGTCCAGCATGCTCTGGCTGTTCGGCGCGCATCCGGACCAGTGGCGGCTGCTGCGCGAGGACGAGGAGCGCATCCCGCACGCCTTCAACGAGATCCTGCGCATCGAGTCCCCGCTGCGCGGCTTCACCCGGCTCACCACGCGCGAGCGCGACCTGGGCGGCGCCCCGCTGGCGGCCGGCTCGCGCGTGCTGCTGCTGTACGGCTCGGCCAACCGCGACGAGCGCCAGTGGGACGACCCCGAGCGGTTCGACATCGGCCGGCCCGGGGTCGCGCAGCACATCGGCTTCGGCCACGGCATCCACGGCTGCGTCGGCCAGGCGCTCTCCCGGCTGGAGGGGCACAGCCTCCTGAAGGCGCTGTCCACGCGGGTGCGCTCGATCGAGATCGGTGAACCCGCCTGGCGGCTGCACAACACGATCCGGGGCATCGCGTCCCTGCCCGTGACGCTGCGGACCTGA	MTTSTVPRSDIDPYSDASILSPYEDYRRLRDLGPVVWLESHQVFAVARYREVYDALHDHTTFSSGSGVGLTETLNKAQKGSSFTSDPPYHGYVRGLVARHLKPKALERFHDYIEGWANRLVDELIEKGTFDAVTDFAQAFPLAVVPDLLGWPVEEGKERLLEWATAGFNAFGPLNERTMSGFPLLKEMSEFLQRMSVPGNLRPGSWGAELVSDAKEGRIEEYLLPGLLGDFLAPSMDTSVSALSSMLWLFGAHPDQWRLLREDEERIPHAFNEILRIESPLRGFTRLTTRERDLGGAPLAAGSRVLLLYGSANRDERQWDDPERFDIGRPGVAQHIGFGHGIHGCVGQALSRLEGHSLLKALSTRVRSIEIGEPAWRLHNTIRGIASLPVTLRT	MRITLGVMKVNLLLVLFFALVLNWPFFLRFYSVISGLEHVRAGFVISVPLVLLAALNAVFIPFTFRWLLKPFFSLLILTGSIVSYAMLKYGVIFDASMIQNIVETNNSEATSYLNVPVVLWFLLTGVLPMVVLWSLKVRYPANWYKGLAIRAGALAFSLLFVGGVAALYYQDYVSIGRNHRILGKQIVPANYVNGIYKYARDVVFATPIPYQPLGTDAKVVAKGDKPTLMFLVVGETARGKNFSMNGYEKETNPFTSQAGGVISFKDVRSCGTATAVSVPCMFSNMGRKEFDDNRARNSEGLLDVLQRSGVSIFWKENDGGCKGVCDRVPNIEIKPKDHPQFCDKNTCYDEVVLQNLDDEVAQMKGDKLVGFHLIGSHRPPYHQRYPDKPPPFVPDCPRSDIENCSDEELVNTYDNTIRYTDFVIAEMITKLKKYEDKYNTALIYLSDHGESLGAMGLYLHGTPYKFAPDDQTRVPMQVWMSPGFAKEKGMDLNCLQQKAADNRYSHDNLFSSVLGIWDVSTAVYDKQLDIFSQCRTVQ	73.10	gnl|BL_ORD_ID|2678|hsp_num:0	3145			1188	1347	colistin A; colistin B
BGC0000211.1|Chrysomycin_16 # 13911 # 14708 # -1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.685	BGC0000211.1|Chrysomycin_16 	13911	14708	-	Loose	300	25.409	AAC(3)-VIIIa	37.93	3002542	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGGTCTGCATAACGCACCCTCACATCCACCCTGAATACCGTGCGACCGATTGCCGGAACGACACGTCGGGCAGTCTGTGCACCGACTGCGAGGAACACCTCTCGGGAATGCTGCAAAGGATTCCGACACTTTACCTGAGCTGTGAACTAAGCCTTGGCGGAGCGAATGCGGCCGAGGAAAGGGTCACCAGCTCCAACAGCCACCAGGGCATGCCGTTCAACGCGGCGGCCGCCGAGGTCCGCTCCTCGATCATGTCGGTCCTGGCCTCCTGGGCCGGCCTCGTCGCCGCGGAGCGGGCGGTCGACGCCCCGCAGCGCCACGTCGTGGGAATGGCCCGCTTCCTCCACGAGAACATCCCCTGGCTCTCGGCCCATCCGGCGGCCCACGACCTGCTCGACGAACTCACCACCCTGACGCGGCTCGCCCGGCGCGCGAGCGACTCCCGCAGCATCCGCGTCATCCCGGTCGGCCCGTGCGTACGGGAAGGCTGCGCCGGCAAGCTGCGCGCCGTGGTCAAGGTCGTCCCCGGCACCCGGCCGAAGCCGTCCGAGATCCGGTGCAGCGCGGACCGTACGCACTGGTGGGCCTCCAGCGAGTGGTCGGCCCTCGCGTCGCGCATGGGGACGCTCCGCGATCACCGGCGCACCTGGTACAGCGTCGCGGACATCGAAGTGCTCTGGAAGATCCCCAGCGGAAGCATCTACCGCCTCGCCAACCAGTACCGGTGGCGCCGCCGCAAGATCTCGGGCCGGGTCTTCTACCACGCCGAGGACCTCCACGACTCGCTCCCCGGCTGA	MVCITHPHIHPEYRATDCRNDTSGSLCTDCEEHLSGMLQRIPTLYLSCELSLGGANAAEERVTSSNSHQGMPFNAAAAEVRSSIMSVLASWAGLVAAERAVDAPQRHVVGMARFLHENIPWLSAHPAAHDLLDELTTLTRLARRASDSRSIRVIPVGPCVREGCAGKLRAVVKVVPGTRPKPSEIRCSADRTHWWASSEWSALASRMGTLRDHRRTWYSVADIEVLWKIPSGSIYRLANQYRWRRRKISGRVFYHAEDLHDSLPG	MDEKELIERAGGPVTRGRLVRDLEALGVGAGDTVMVHTRMSAIGYVVGGPQTVIDAVRDAVGADGTLMAYCGWNDAPPYDLAEWPPAWREAARAEWPAYDPLLSEADRGNGRVPEALRHQPGAVRSRHPDASFVAVGPAAHPLMDDHPWDDPHGPDSPLARLAGAGGRVLLLGAPLDTLTLLHHAEARAEAPGKRFVAYEQPVTVGGRRVWRRFRDVDTSRGVPYGRVVPEGVVPFTVIAQDMLAAGIGRTGRVAAAPVHLFEAADVVRFGVEWIESRMGGAAGGA	92.66	gnl|BL_ORD_ID|461|hsp_num:0	501			351	438	neomycin
BGC0000211.1|Chrysomycin_18 # 15081 # 15758 # -1 # ID=1_18;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.643	BGC0000211.1|Chrysomycin_18 	15081	15758	-	Loose	390	52.7582	evgA	20.6	3000832	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGAGCGACCTGACCGGGCGCGGATGGCGGACGCAGGACGCCGAGTGCTCGCGATCACCTCTTGGGGGAAAAGTGATTAACGTCTTGCTCGCCGAAGAGAGGGAAATGACACGAGGGGCATTTCTCGCCCTACTCGCGCAGGAGAGCGACATCAAGACCGTCGCCGACCTGGGTCGGAGCAAGGACATTCTGCCCGCGATCAGACTGCACCGGCCGGACGTGGCAGTCATCGACATGGATATGCTGACCCCGGACGGCCTGTCATCGATTCAGAGCCTTTTCGACGAGCTGCCGGAAACACGTACTCTCATTCTCACCAATCATGGGCGCCCCGGTGTGGTGCGTCAAGCGCTGAACATCGGCGTCGCGGGTTTTCTGCACAAGGACTCACCGCCGGAGAAACTCGTCAGCGCTATAAGGGATCTCGCGGCGGGACGACGTGTCATCGACGCGGATCTCGCGATGTCCGCCTGGCAGACGCCGCTCCCCCCGCTCACCGACCGCGAGCTCGAGGTGCTCCGCCTGACCGCCACCGGCGAGGCTGTTCCGGCCATCGCCACACGACTCCACCTGTCCCCCGGCACCGTCCGCAACTATCTGACCACCGTGGAGAGCAAACTCAACGCGCGCACGCGAGTGGACGCCGTGCGCATCGCCACGGACGCCGGCTGGCTCTGA	MSDLTGRGWRTQDAECSRSPLGGKVINVLLAEEREMTRGAFLALLAQESDIKTVADLGRSKDILPAIRLHRPDVAVIDMDMLTPDGLSSIQSLFDELPETRTLILTNHGRPGVVRQALNIGVAGFLHKDSPPEKLVSAIRDLAAGRRVIDADLAMSAWQTPLPPLTDRELEVLRLTATGEAVPAIATRLHLSPGTVRNYLTTVESKLNARTRVDAVRIATDAGWL	MNAIIIDDHPLAIAAIRNLLIKNDIEILAELTEGGSAVQRVETLKPDIVIIDVDIPGVNGIQVLETLRKRQYSGIIIIVSAKNDHFYGKHCADAGANGFVSKKEGMNNIIAAIEAAKNGYCYFPFSLNRFVGSLTSDQQKLDSLSKQEISVMRYILDGKDNNDIAEKMFISNKTVSTYKSRLMEKLECKSLMDLYTFAQRNKIG	110.29	gnl|BL_ORD_ID|936|hsp_num:0	1015			0	594	erythromycin; cloxacillin; tetracycline; oxacillin; norfloxacin
BGC0000211.1|Chrysomycin_19 # 15930 # 16916 # -1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=14bp;gc_cont=0.703	BGC0000211.1|Chrysomycin_19 	15930	16916	-	Loose	1200	50.447	arnA	26.04	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGACGACCACTCATCTCCTGGTCACCGGCGGGGCGGGGTTCATCGGCTCGCACTACGTGCGCACTCTGCTCTCCCCCGAGGGCCCCGGCGACATCTCCGTCACCGTGCTCGACGCGCTGACCTACGCGGGGAACCCGGCCAACCTCGACCCGGTGCGCGCGCATCCCGGCTTCACCTTCGTCCGGGGCGACATCTGCGACGCGCCGCTGGTGAGGTCCCTCGCCCGTCGCGCCGACCAGATCGTGCACTTCGCCGCCGAGTCGCACGTGGACCGCTCGATCACGGACCCGGCCGCGTTCACCCGGACCAACGTGATGGGAACGCAGATCCTGCTCGACGCGGCGCTGCGCGCCGGTACGCGCACGTTCGTCCACATCTCGACGGACGAGGTCTACGGGTCCATCGACGAGGGCTCCTGGCCGGAGGACCACCCCCTCCGCCCCAGCTCGCCGTACGCGGCGTCCAAGGCGTCGAGCGATCTCCTCGCCCTGAGCCACCACCACACCCACGGCCTGGACGTGCGGGTGACCCGGTGCTCCAACAACTACGGGCACCACCACTTCCCCGAGAAGGCCATCCCCCTGTTCGTGACCCGTCTCCTCGACGGAAGGAAGGTGCCCCTGTACGGCGACGGGCGCAACGTCCGGGACTGGCTGCACATCGACGACCACGTGCGGGCCGTCGAGCTGGTGCGCACGAGCGGAAGACCCGGCGAGGTCTACAACATCGGCGGCGGCACCGAGCTGACCAACCGGCAGCTCACCGAGCGGCTGCTCGCGGAGTGCGGAGCCGGCTGGGACATGGTCGAGCACGTGGCCGACCGCCCGGGGCACGACCTGCGCTACTCGGTCGACTGGACCAAGATCCACACCGAGCTGGGCTACCGGCCGCGCAAGGACTTCGCCACGGGGCTCGCCGAGACCGTGGCCTGGTACCGCGAGAACCGCCCGTGGTGGGAACCCCTGAAGGAGCGCGCCATGCTGTGA	MTTTHLLVTGGAGFIGSHYVRTLLSPEGPGDISVTVLDALTYAGNPANLDPVRAHPGFTFVRGDICDAPLVRSLARRADQIVHFAAESHVDRSITDPAAFTRTNVMGTQILLDAALRAGTRTFVHISTDEVYGSIDEGSWPEDHPLRPSSPYAASKASSDLLALSHHHTHGLDVRVTRCSNNYGHHHFPEKAIPLFVTRLLDGRKVPLYGDGRNVRDWLHIDDHVRAVELVRTSGRPGEVYNIGGGTELTNRQLTERLLAECGAGWDMVEHVADRPGHDLRYSVDWTKIHTELGYRPRKDFATGLAETVAWYRENRPWWEPLKERAML	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	49.55	gnl|BL_ORD_ID|1513|hsp_num:0	1643			951	1764	polymyxin B
BGC0000211.1|Chrysomycin_20 # 16913 # 17980 # -1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.675	BGC0000211.1|Chrysomycin_20 	16913	17980	-	Loose	450	28.4906	ANT(9)-Ia	34.78	3002630	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(9)	ATGAAGGCGCTCGTCCTCTCGGGCGGTGCGGGTACGCGCATGCGCCCGCTCACGCACACCACGGCGAAACAGCTGGTCCCGGTAGCCAACAAGCCTGTTCTGTTCTACGGCCTCGAAGCCATCGCACAAGCCGGCATCACGGACGTGGGAATCATCGTGGGCGAAACGGCGGACGAGATCGAGGAGGCGGTGGGCGACGGCTCCAAATTCGGACTCGACGTCACCTACATCCCCCAGGAGGCGCCGCTCGGACTCGCCCACGCCGTGCTGATATCCCGCTCATTCCTGGGGGACGATGAATTCGTCATGTATTTGGGCGACAACTTCATCGTCGGCGGCATCACCGAACTGGTGGACAATTTCGTGTCGGACCGCCCCGACGCCCAGATCCTGCTGACCCACGTCCCCAATCCCACCGTCTTCGGCGTCGCCGAGCTGGACGACGCGGGCAACGTCGCGCGCGTGGAGGAGAAGTCCCCCTGCCCCAGGAGCGACCTCGCGATCGTCGGGGTGTACCTGTTCGGTCCGGCCGTCCATGAGGCGGTGCGTGCGATCAAGCCCTCCGGGCGCGGGGAGCTGGAGATCACCCACGCCATCCAGTGGCTCATCGACGAGGGGCGCGACGTGCGCTCCACGACGATCTCCGGCTACTGGAAGGACACCGGCAACGTCGTGGACATGCTGGAGGTCAACCGGTCGGTGCTGGAGACGCTCGAACCCCGGATCGAGGGCGAGGTGGACGAGGCGAGCCAGATCATCGGCCGGGTCCGCATCGAGGAGGGCGCGCGCGTGCGCGGCTCCCGCGTCGTCGGCCCCGCCGTCATCGGCCGGGGCACGGTGATCAGCGACTCCTACATCGGCGCGTACACGTCGGTGTCGGAGGACTGCCGCGTGGAGAACAGCGAGATCGAGTTCTCGATCGTGCTGCGGGACTCGTCGATCAAGGGGGTGCGCCGGGTCGAGGCGTCCCTGATCGGACGCAACGTCACGGTGACGCCGGCCCCGGCCGTCCCGCACGCCCACCGGCTCCTGCTGGGCGACCACAGCGAGGTGCAGATCTCGTCATGA	MKALVLSGGAGTRMRPLTHTTAKQLVPVANKPVLFYGLEAIAQAGITDVGIIVGETADEIEEAVGDGSKFGLDVTYIPQEAPLGLAHAVLISRSFLGDDEFVMYLGDNFIVGGITELVDNFVSDRPDAQILLTHVPNPTVFGVAELDDAGNVARVEEKSPCPRSDLAIVGVYLFGPAVHEAVRAIKPSGRGELEITHAIQWLIDEGRDVRSTTISGYWKDTGNVVDMLEVNRSVLETLEPRIEGEVDEASQIIGRVRIEEGARVRGSRVVGPAVIGRGTVISDSYIGAYTSVSEDCRVENSEIEFSIVLRDSSIKGVRRVEASLIGRNVTVTPAPAVPHAHRLLLGDHSEVQISS	MSNLINGKIPNQAIQTLKIVKDLFGSSIVGVYLFGSAVNGGLRINSDVDVLVVVNHSLPQLTRKKLTERLMTISGKIGNTDSVRPLEVTVINRSEVVPWQYPPKREFIYGEWLRGEFENGQIQEPSYDPDLAIVLAQARKNSISLFGPDSSSILVSVPLTDIRRAIKDSLPELIEGIKGDERNVILTLARMWQTVTTGEITSKDVAAEWAIPLLPKEHVTLLDIARKGYRGECDDKWEGLYSKVKALVKYMKNSIETSLN	136.54	gnl|BL_ORD_ID|1270|hsp_num:0	1386			78	282	spectinomycin
BGC0000211.1|Chrysomycin_21 # 18285 # 19937 # -1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.699	BGC0000211.1|Chrysomycin_21 	18285	19937	-	Loose	1050	163.31	facT	30.0	3001313	protein homolog model	n/a	n/a	elfamycin antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGCAAAGATACATCAGAGTGGAGGTACCTTGAACGGCACCACGGAACCCCCATCCATGCGCCAATGGCTCGGCCTGGTGGCAGTTTCCTTGGGTGTGGCGCTGATCGTCGTCGACATCACGATCGTCAACGTCATCCTGGCCCCGATCATCGAGGACCTCTCGATCGATTCCGCCGAGGCCCAGTGGATCCAGGAGTCCTACGCGATCGCCTTCGCGGCCCTCCTCCTGCTCGCCGGACGCCTCGCCGACCTGTACGGCGCCCGCAGGATCTTCGTCTACGGTCTCGTCGTCTTCGCCGTCACGAGCCTGGTGGCCGCCCTCTCCCCCGACGGCGGCCTGCTGATCCTGGCCCGCGCACTGCAGGGGGTCGGCGGCGCCATGATCCTCCCGACCTCACTGGCGCTGGTGAACGCCACCTTCACCGGCAAGGCCCGGGGTCAGGCCTTCGCCATCTGGGGCTCGACCATCGGCGCCGCGGCTGCCGTGGGCCCGCTGCTCGGCGGCTGGCTGGCCGACATCTCCTGGCGCTGGGCCTTCGGCATCAACATCCCCCTGGTCGCCCTGATCATGGTCGGGACGCTCGTCCACCTGTCCGAGTCCCCGCGAACCCGGGGCCGCGTCGACGGAGTCGGCGGCGTCCTGTCGGCGGTCGGCCTCGGCCTGCTGGCGTTCGCCCTGATCGAGGGGCGCACCTACGGCTGGCTGATGACCACCGAGTCCCTCGACGTCGGCGGCCTCTCGTGGAGCGGCGGCCTCTCCCCCGTGTGCGTCTCGTTCGTCGTGTCGGCGGTGGTCCTGTGGGCGTTCTGGCGCCGTCAGGCGGCGCTGGGCCGCAGGAACGGAGAGCCGCTGATGGACGTCGGCCTCTTCTCCATCCCGTCCTTCCGCAACGGCAACGTCGTGACGCTGATGGTCGGACTCGGCGAGTTCGGCATCATCGCCGTACTGCCGCTGTGGCTGCAGTTCACCCTGGACTACAGCGCGTTCGACGCCGGACTCGCGCTCGTCGCGCTCGCGGTGGGCAGCTTCGTCGCCAGCGGAGCGAGTTTCGGCATGGCCGCCACGGTCCCGCCGCTCTCCCAGGTGCGGATCGGTCTCGTCCTGGAGGCCGCCGGCCTGGTGATGCTGGGCCTGATCGCCGCGACCGACACCTCCTGGTGGACGATCGCGATCGCCCTGTTCGTCTACGGCGTCGGCGTGGGCTTCGCGACGGCGCAGGTCACCAACATCGTGCTGGTGGACGTTCCCCCGCGGAGCGCCGGACAGGGGTCGGGCATCCAGAGCGCGGCCCGGGAACTGGGCTCCGCGCTGGGTATCGCCGTCCTGACCACGCTGTTCTTCAGCACCCTCGCCACCGATCTGAACGACCGGCTCACCGACTCCGGCCTGAAGGACGCCGAGGCCGACCGGTTCAGTTCGGTCGTCACGGACAGCGCGGGCTCGGTGATCCAGTCGCTCTCCGACGACAAGCGGACCGCCGCGGTCGCGGACGCGGCCAGAGAGGCGATGTCCCACGGCCTGGCGATGGCCTCCTACGTGTGCGCCGGACTGCTGGCCCTGGCCCTGGTGACCACGCTGTTCGTCACCCCTCGCGAGGGCGCCCCCACCGAGGAGGCGAAGGCCGCGCACCCCGAACCGACCACCAACTGA	MAKIHQSGGTLNGTTEPPSMRQWLGLVAVSLGVALIVVDITIVNVILAPIIEDLSIDSAEAQWIQESYAIAFAALLLLAGRLADLYGARRIFVYGLVVFAVTSLVAALSPDGGLLILARALQGVGGAMILPTSLALVNATFTGKARGQAFAIWGSTIGAAAAVGPLLGGWLADISWRWAFGINIPLVALIMVGTLVHLSESPRTRGRVDGVGGVLSAVGLGLLAFALIEGRTYGWLMTTESLDVGGLSWSGGLSPVCVSFVVSAVVLWAFWRRQAALGRRNGEPLMDVGLFSIPSFRNGNVVTLMVGLGEFGIIAVLPLWLQFTLDYSAFDAGLALVALAVGSFVASGASFGMAATVPPLSQVRIGLVLEAAGLVMLGLIAATDTSWWTIAIALFVYGVGVGFATAQVTNIVLVDVPPRSAGQGSGIQSAARELGSALGIAVLTTLFFSTLATDLNDRLTDSGLKDAEADRFSSVVTDSAGSVIQSLSDDKRTAAVADAAREAMSHGLAMASYVCAGLLALALVTTLFVTPREGAPTEEAKAAHPEPTTN	MNKAGQAEKPAAAGPPATPETPEPDPKRWLALTVLLVATFMDLLDANIITVAIPSIQRDLGASTFAIQAMTAGYTLSFAVLLITGGRLGDIFGRKRMFLVGVGGFVLASAMCAAAPSTDLLVVARALQGLTAAVMVPQVLALIHVSFAPQEIGRVVSLYASMVGLAIVSGPLIGGALISWNPLDLGWRSIFVVNLPVGVLALVGAAKWMRESSSPHAKRLDIAGMLLIVLGLLLLMVPLTLGRELDWPVWSIVSLVAAAPVLVLFVVYERHKTAKDGSPLVTLSLFKVRAFGAGIGVQLLFSAIPAGFFLSWTLYLQAGLGWSALHTGLTAIPFSLCVPIVGGLAVRRLSPLYGRYCLLAGAVLMLAGILSYAWAADRFGTDITSWHAIPSMLLIGSGMGMLMPPLTALVLREVQPQEAGAASGIINATGQLGAALGVAVIGSLFFAALAGNAGPQAERVAPTVQSVSPRQASDLRDCATEALGQDDLAKVPDICSTLVQGADDGTRDTINGALGEIRAKTFVSTYSETLYWAAGGLVPVTALVLLLPHHRVRREEPAQ	98.39	gnl|BL_ORD_ID|1345|hsp_num:0	1469			78	1497	factumycin
BGC0000211.1|Chrysomycin_22 # 20015 # 20542 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=10bp;gc_cont=0.693	BGC0000211.1|Chrysomycin_22 	20015	20542	+	Loose	270	29.6462	mgrA	29.09	3000815	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; penam; tetracycline antibiotic; peptide antibiotic; disinfecting agents and antiseptics	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump	ATGACGATGGAGAGAGCAGACCTCGGCGGGCTGGAGGTACAGCGCGACCGGCTCATGGACGGGCTGCGCGCCTTCGGTGCCAACTACGCGGAGTTCACCCAGCGGTTCGCGACCTGGCTGGGCCTGCACTCCACCGACGCCGCGGCTCTCGTCGAGATCCTCTACGCCGAGGACAAGGGGGCGCCGCTGTCACCCGCCCGGCTGAGCGAGCGTGTCTCCCTGTCGTCGGGCGCGACGACCGCGCTGCTGAACCGTCTCGAGGCGGCCGGACACATCGTGCGCACCCGTGAACACACCGACCGCAGGATCGTGACCCTGCGCAGCAGCCCCCATGTGAAGCCGCGCGCCGAGGAGTTCTTCGGCCCCTACGCCGGACGCATGGTCGCCGAGATGTCGCAGTACACCCCCGAGCAGCTCCAGCAGTTCGAGGACTTCATCGTCCACCTGCGCGAGACCATGGACTCGCTGCTCGCCCACGAGTACAAGGAGAGCCGGCCGGGCGGCTCAGGAGCGTCCGACCGGGGCTGA	MTMERADLGGLEVQRDRLMDGLRAFGANYAEFTQRFATWLGLHSTDAAALVEILYAEDKGAPLSPARLSERVSLSSGATTALLNRLEAAGHIVRTREHTDRRIVTLRSSPHVKPRAEEFFGPYAGRMVAEMSQYTPEQLQQFEDFIVHLRETMDSLLAHEYKESRPGGSGASDRG	MSDQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVVTELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTDKSETIRPELSNASDKVASASSLSQDEVKELNRLLGKVIHAFDETKEK	119.05	gnl|BL_ORD_ID|133|hsp_num:0	154			126	282	methicillin; ciprofloxacin; acriflavine; tetracycline; daptomycin; moxifloxacin; cefotaxime; norfloxacin; sparfloxacin; moenomycin A1
BGC0000211.1|Chrysomycin_23 # 20581 # 20727 # 1 # ID=1_23;partial=00;start_type=TTG;rbs_motif=GAG;rbs_spacer=5bp;gc_cont=0.680	BGC0000211.1|Chrysomycin_23 	20581	20727	+	Loose	700	23.0978	mdtM	28.57	3001214	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; lincosamide antibiotic; nucleoside antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TTGACAGGCCGAACTGCGGCGAAGAAGATACTGCCCATCGTGGAACGTGTGTGCCCGTCGGCCCCGTTCCCTCTCCCGCCGACCGGTTCCGGCCTCCTGTTCCCCGTGCACGTGGACATCCCGTGGCACGAGCGGCGCCGACCGTGA	MTGRTAAKKILPIVERVCPSAPFPLPPTGSGLLFPVHVDIPWHERRRP	MPRFFTRHAATLFFPMALILYDFAAYLSTDLIQPGIINVVRDFNADVSLAPAAVSLYLAGGMALQWLLGPLSDRIGRRPVLITGALIFTLACAATMFTTSMTQFLIARAIQGTSICFIATVGYVTVQEAFGQTKGIKLMAIITSIVLIAPIIGPLSGAALMHFMHWKVLFAIIAVMGFISFVGLLLAMPETVKRGAVPFSAKSVLRDFRNVFCNRLFLFGAATISLSYIPMMSWVAVSPVILIDAGSLTTSQFAWTQVPVFGAVIVANAIVARFVKDPTEPRFIWRAVPIQLVGLSLLIVGNLLSPHVWLWSVLGTSLYAFGIGLIFPTLFRFTLFSNKLPKGTVSASLNMVILMVMSVSVEIGRWLWFNGGRLPFHLLAVVAGVIVVFTLAGLLNRVRQHQAAELVEEQ	11.71	gnl|BL_ORD_ID|1098|hsp_num:0	1191			390	495	acriflavine; lincomycin; puromycin; chloramphenicol; norfloxacin
BGC0000211.1|Chrysomycin_24 # 20814 # 21953 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5bp;gc_cont=0.725	BGC0000211.1|Chrysomycin_24 	20814	21953	+	Loose	700	37.3502	oleD	24.33	3000865	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGAAAGTCCTCTTCATCGCCGCGGGAACGAGCCCGGCGGGGGTCTTCGCCCTCGCCCCTCTCGCGACGGCGGTGCGCAACGCAGGGCACGAGATCCTGGTGGCGGCCTTCGACGAGCTGACCCCGGCCGTCGCGTCCGTCGGACTGCCCGTCGTGGCCGTCGCCGACGGCCACACGACCGAGAGCATCAAGGGACTCGACCGGCCGGGCGGACCGATCGGGTTCCCCTGGGCACCCGAGCAGGAACTGCCGTACGTGGGACGTTGGTTCGGCCGCCAGGCGGCCGTCGCCATGGACGGACTCCTGCGGCTCGCCGACGTGTGGCGCCCCGACCTCGTGGTCGGTGGCACGGACGCCCACGCCGCCGCCCTGCTCGGCTCCCGGCTGGGCATCCCGTACGTCCGCCAGGCGTGGGACTGGCTCCACTTCGACGGAGCGGAGCGCTACGCGAACGACGAACTGGCCCCCGAACTGGCGCAGGCCGGACTCGAACGGCTCCCGGCACCCGACCTGTTCATCGACATCTGCCCGCCGAGCCTGATCCCGCCGGGCGCCGAGCGCGGCCGGCCGATGAGATGGGTGCCGGGCAACCGCCAGCGCAAGCTGGAGCCGTGGATGTACGGCAAGGGCGAGCGCGCCCGGGTGTGCGTCACGCTCGGCAGCTTCCGCACCGCCATGCCGGAGATGTTCGCCTACCTGTGCGCACTGGTGGAGCGGCTGACGGCACTCGACGCCGAGATCGTCGTCGCCGCCGACGAGACGGCCTCCCGGAAGATCCGGGAGCGCTTCCCCGGCGTACGCGCCGACTGGGTGCCGATGGAGTTCCTCGTGCGCACCTGCGACACGATCGTGCACGCGGGCGGCCTCACCACTCTCAACGCCATGGCGGCCGGCACCCCGCAGGTGGTGGTGAACCAGTTCCAGGCGTTCGAACCCTCGCTGCGGCTGCTCGAGCGGCAGGGATGCAGCGTGGTCCTGCACCGGGACGACAAGTCCCCGGACAACACCTTCGACGCCTGCGAGCGCATCCTCTCCGACGACGGGTACGCGCACCGGGCAGGTGAGCTGGCCCGCGAACTGGGCGCCCTGCCCCCGCCGGCCACGGTCGTCGGCGACCTGGAGGCGCTGGCCCGCCGCTGA	MKVLFIAAGTSPAGVFALAPLATAVRNAGHEILVAAFDELTPAVASVGLPVVAVADGHTTESIKGLDRPGGPIGFPWAPEQELPYVGRWFGRQAAVAMDGLLRLADVWRPDLVVGGTDAHAAALLGSRLGIPYVRQAWDWLHFDGAERYANDELAPELAQAGLERLPAPDLFIDICPPSLIPPGAERGRPMRWVPGNRQRKLEPWMYGKGERARVCVTLGSFRTAMPEMFAYLCALVERLTALDAEIVVAADETASRKIRERFPGVRADWVPMEFLVRTCDTIVHAGGLTTLNAMAAGTPQVVVNQFQAFEPSLRLLERQGCSVVLHRDDKSPDNTFDACERILSDDGYAHRAGELARELGALPPPATVVGDLEALARR	MTTQTTPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPVFADKVAATGARPVLYHSTLPGPDADPEAWGSTLLDNVEPFLNDAIQALPQLADAYADDIPDLVLHDITSYPARVLARRWGVPAVSLSPNLVAWKGYEEEVAEPMWREPRQTERGRAYYARFEAWLKENGITEHPDTFASHPPRSLVLIPKALQPHADRVDEDVYTFVGACQGDRAEEGGWQRPAGAEKVVLVSLGSAFTKQPAFYRECVRAFGNLPGWHLVLQIGRKVTPAELGELPDNVEVHDWVPQLAILRQADLFVTHAGAGGSQEGLATATPMIAVPQAVDQFGNADMLQGLGVARKLATEEATADLLRETALALVDDPEVARRLRRIQAEMAQEGGTRRAADLIEAELPARHERQEPVGDRPNGG	91.33	gnl|BL_ORD_ID|1253|hsp_num:0	1367			264	1158	erythromycin; tylosin
BGC0000211.1|Chrysomycin_25 # 22072 # 23094 # 1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=11bp;gc_cont=0.737	BGC0000211.1|Chrysomycin_25 	22072	23094	+	Loose	300	30.8018	AAC(3)-Xa	38.6	3002544	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGCAGACCACACCCCCCAAGCCGCCGCCCTCCGCACAGGTGCTGCAGCTCGCGACGTCGAGCTGGACGGCCGCCGCCGTGAGCGCCGCCGCCGAACTCGGCGTCGCCGACGCGCTGGCGGACGGAGCCCGCCCGTCCGACGAGATCGCCCGGAGCGTCGGCGCGCACCCGCCCACCTGCTACCGCCTGCTGTGGGCCTGCGCCGCCATCGGGCTGCTGGAGGAGAGCGAGGGGCGGGTGTTCGCCCTCACCGAGGCCGGTGACGCGCTCCGCGGCGACTCGCCACACTCCATGCGCAACTTCGCCCGGTGGGTCGGCCTCGCCGCCGACCGCAACACCTGGGCCGGCCTCGCCGACAGCGTCCGCACCGGCGATCCCGCGTTCGCGCGGGTGCACGGCCAGGACGTGTGGGAGTACATGAGGGATCGCGCCGACGTCTCGACGGTCTTCGACGACGCGATGACCGAGGCGTCGCGTCAGCTGATCGCCCCGGTGGTCGACGCCTACGACTTCGGCGGCACCGGCACGCTCGTGGACGTCGCGGGCGGGCACGGAGCCCTCCTCGCCGCGATCCTCGCCGCCCACCCGGGCCTCCGCGGCCTGCTGTACGACCGGCCCGAGGTGGTGGAGGGGGCGAAGCAGACGTTCCAGGACCGCGGGGTGGACGACCGGGTGGAGATCGTCGCCGGCGACTTCTTCGACTCCGTGCCGGAGGGCAAGGACGCCTACCTGCTGTCGAACGTCATCCATGACTGGGACGACGAGCCGTCCCTGACGATCCTCGGCAACTGCCGCCGCGCGCTCGCCGAGGGCGGCCGGGTGCTCCTCGTCGAGGCCGTCATGCCGGAGCGGGACGCGTCCTCGCCGACCGTGACCCTGATGGACCTCAACATGCTCGTGCTCTGCGGCGGCAAGCAGCGCACCGAGACCGAGTTCGCCGAACTCCTCGGCCGCGCCGGTCTCCGCCTCACCCGCGTCGTCCGGGCGGGACTGCACAGCGTCGTCGAGGCCGTCCGCGCCTAG	MQTTPPKPPPSAQVLQLATSSWTAAAVSAAAELGVADALADGARPSDEIARSVGAHPPTCYRLLWACAAIGLLEESEGRVFALTEAGDALRGDSPHSMRNFARWVGLAADRNTWAGLADSVRTGDPAFARVHGQDVWEYMRDRADVSTVFDDAMTEASRQLIAPVVDAYDFGGTGTLVDVAGGHGALLAAILAAHPGLRGLLYDRPEVVEGAKQTFQDRGVDDRVEIVAGDFFDSVPEGKDAYLLSNVIHDWDDEPSLTILGNCRRALAEGGRVLLVEAVMPERDASSPTVTLMDLNMLVLCGGKQRTETEFAELLGRAGLRLTRVVRAGLHSVVEAVRA	MDETELLRRSDGPVTRDRIRHDLAALGLVPGDTVMFHTRLSAIGYVSGGPQTVIDALLDVVGPTGTLLVTCGWNDAPPYDFTDWPPAWQEAVRAHHPAFDPRTSEAEHANGRLPEALRRRPGAVRSRHPDVSLAALGASAPALMDAHPWDDPHGPGSPLARLVALGGRVLLLGAPRDTMTLLHHAEALAQAPGKRFVTYEQPIEVAGERVWRTFRDIDSEHGAFDYSSAVPEGQDPFAVIVGSMLAAGIGREGFVGAARSRLFDAAPAVEFGVRWIEEHLNRDR	119.72	gnl|BL_ORD_ID|1365|hsp_num:0	1483			552	711	kanamycin A
BGC0000211.1|Chrysomycin_26 # 23186 # 23896 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.665	BGC0000211.1|Chrysomycin_26 	23186	23896	+	Loose	400	24.6386	catA4	23.53	3004657	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGCCATTCATCACGCCCGACAACGGATCGCTCACCGTGTTCAACCTCTTCGACACCGTCGACAGGGACGGCCAGAAGACCCTGCTGGACACGATGGAGGGGATCATCAAGGGGGCGAACTACCCGGGGTGGCGCTCCTCCACCCTGCACGGCGGCCTCGACAAGCCCTGTGCCGCGAACTACATCCAGTGGCGCAGCGTGGACGATCTGCAGGAGCGCTACGAGGGTGAGAACTTCCGGCACAACACGGTGCCCTACTTCAAGGAACTGACCACCACGGTGCACCTGCTGAAGACCGAGGTGATCGCCACCCACCTGCATCCCGGGCTCGAGCGGATAGAGATCTCGCCGGAGCGGGACGACTTCACCGTCATCGTCGTCATGGGTGTCGAGCCCGAGAACCAGGCCACCCTCGTGGACCTGTTCGCGAAACCCGACTCCGCCATGGCGGACGTGCCGGGATACCGGTCCAACTCCATCCTGCGCGGCCTCGACGGTGACTTCGTCGTCAACTACGCCCAGTGGGACAGCCGCGAGGCGTACGAGACGTTCCACGGCCTGCCGGAGGACCGGCGTCCCGCGCACACCCGGGCCATGCGCGCGCAGGCGCGCCCGCTGCTGACGTCACGGTCGTCGAACACCTACGAGGTCGTGTTCGCGCGGTCCGCGAGCGACCAGCCGTCCACCGAGCAGCCGGCCGGTGACCGATGA	MPFITPDNGSLTVFNLFDTVDRDGQKTLLDTMEGIIKGANYPGWRSSTLHGGLDKPCAANYIQWRSVDDLQERYEGENFRHNTVPYFKELTTTVHLLKTEVIATHLHPGLERIEISPERDDFTVIVVMGVEPENQATLVDLFAKPDSAMADVPGYRSNSILRGLDGDFVVNYAQWDSREAYETFHGLPEDRRPAHTRAMRAQARPLLTSRSSNTYEVVFARSASDQPSTEQPAGDR	MDTKRVGILVVDLSQWGRKEHFEAFQSFAQCTFSQTVQLDITSLLKTVKQNGYKFYPTFIYIISLLVNKHAEFRMAMKDGELVIWDSVNPGYNIFHEQTETFSSLWSYYHKDINRFLKTYSEDIAQYGDDLAYFPKEFIENMFFVSANPWVSFTSFNLNMANINNFFAPVFTIGKYYTQGDKVLMPLAIQVHHAVCDGFHVGRLLNEIQQYCDEGCK	108.76	gnl|BL_ORD_ID|2198|hsp_num:0	3357			18	162	chloramphenicol
BGC0000211.1|Chrysomycin_27 # 23893 # 26178 # 1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.734	BGC0000211.1|Chrysomycin_27 	23893	26178	+	Loose	550	32.3426	RlmA(II)	22.69	3001301	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGACCGTGCGCGCGGCGGACGACGGGGCGGTCCGCACCGCCCCCGGGCCGCCTCCCCTCCCCGGACCGGTCCGCGTCGGGCCGGACGACCCCCGCTACGGCGAACTGGTGCGCGGCGACAACCACCGCTTCACCGGCACGCCCGACCACGTCGAACTGGTCCGCTCCACCGAGCAGGCCGAGGACGCCCTCCGCCGGGCGCTGGCCGCCGGGCAGCGGGTCGCCGTGCGCAGCGGTGGCCACTGCCCGGAGGCGTTCGTGGCCGGCCCGGAGGTCGAGGTCGTCATCGACCTCTCCCTCATGTCGCGGGTCTCCTACGACCCGGAGCTCAACGCCGTCGCCATCGAGGCCGGGGCGACCGTCGGGCACGTGTACAAGGAGCTGTACCGGAACTGGAACGTGACCCTGCCGGCCGGTGTGTGCACCGCGGTCGGGGTCGGCGGCCACATCTCGGGCGGCGGGTACGGACCGCTGTCCCGGCTGCACGGCCTCGTCGCGGACCACCTCCACGCGGTCGAGGTCGTCCACGTCGACCGGTCCGGCCGGGTGCGCACCGTGATCGCCACCCGGGAGCCGGACGACCCCCACCGGGAGCTCTGGTGGGCCCACACCGGCGCGGGCGGCGGCAACTTCGGCATCGTCACCCGCTTCTGGATGCGTTCCCCCGGGGCGAGCGGCACCGACCCCGCCGGTCTGCTGCCCCGGCCGCCCGCCTCGCTGCTGACCGCGATGGTGAACTGGACGTGGGAGCAGTGCGAGCTGCCCGCGTTCACCCGGATCGTCCGCAACTTCATGGGCTGGCACGTCGCCAACAGCGCCCCCGGCTCGCCGTCCGCCGGGCTGTTCGCCTCGCTGTGGGTCAGACACCGCTCGGGCGGCGGGCTCACCATGTTCGTGCAGGCCGACGCCACGGAGCCGGACGCCGCGGCCGGGCTGGACGCGTTCCTCGCCGCCGTCGACGAGGGCGTCGGCGTCACCCCGTTCGTCCACCGCAGGGAACTGCCGTGGCTGACCGCCAGCCGGTACATGGGGCAGGGCGACTCCGGCCCCGTGATGGGGGCGCGGATCAAGACCAAGGCCGCCTATCTGCGGGACGTGCACACCGACGAGCAGATCGCCACCCTGTACCGGTGGTTCCACCGCGAGGACTACTTCGGCCGTGAGTCCCTGATGATGCTCAACGGCTACGGCGGCGCGATCAACGCGGTCGGACCGGCGGACACCGCGTCGGTCCAGCGGGACTCGGTGATCAAGGCGGCGTACTCGGCGTCCTGGGGCGACCCGGAGGAGGACGAGACGCACCTGACCTGGCTGCGCGGGCTCTACGGCGAGCTGTACGCCGGCACGGGCGGGGTGCCGGTGCCCGGCGGGCCGACGGACGGGTCGTACATCAACTACCCGGACATCGACCTCGCCGACCCGGACCACAACCGGTCGGGGGTGCCCTGGCACCAGCTCTACTACAAGGACAACTACGCGACGCTGCAGGCCGTCAAGGCGGCATGGGATCCCCGTGACGTCTTCCACCACGCCCTGTCCGTGCGGCTGCCGGAGGACGACATGACCTACCCCACCGCCCACATTCCCGAGCACTACGACTTCCGGGCCATCTACGCGGGCGAGAAGGACGCGTCGCCCGTCCAGCCGTGGGACATCGGCCGGCCGCAGCCCGCCCTGGTGGCCGCGCACGACGCGGGGGAGATCACCGGCGACGTCCTGGACGTCGGCTGCGGTCTCGGCGACAACGCCGCCTTCCTCGCCGGGCGGGGCCACCGGGTCACGGCGGTCGACGTGGCCGAGGCGGCCGTGCGGGAGGCGCGGCGTCGGGCAGAGGACAGTGGCGTCGACGTCGAGTTCGCCGTCGCGGACGCCACCCGGCTGACGGGGTACGACGGCCGCTTCGACACGGTCGTGGACAGCGCCTGCTTCCACTCGCTGTCCGAGGACGAACGGGAGCGGTACCTCCGCGCGCTGCGCACGGCGACCCGGCCGGGAGGCAGGCTGCACATGTTCTGCTTCGCCCAGGAGTTCGAGGCCCCGTTCCCGGGGCCGCACCGGCACACCGCAGCCTCCCTGCGCGAGATGGTCGGCGGTGTCTGGAACGTGCTCTCCGTGGAGGCCGCGACCTTCGCCAGCTCCCTCGGCGTCGAGGACATCGCCGCCCTGATCGAGTCGGAGTACCCGGACGGCGACGTCGACCCGGCCCGGCTCGACGGGCTCCCGCTCGACGAGCACGGCAAGGCCACGATGCCGGTCTGGCACGTGACCGCGGAACGCCGCGACTGA	MTVRAADDGAVRTAPGPPPLPGPVRVGPDDPRYGELVRGDNHRFTGTPDHVELVRSTEQAEDALRRALAAGQRVAVRSGGHCPEAFVAGPEVEVVIDLSLMSRVSYDPELNAVAIEAGATVGHVYKELYRNWNVTLPAGVCTAVGVGGHISGGGYGPLSRLHGLVADHLHAVEVVHVDRSGRVRTVIATREPDDPHRELWWAHTGAGGGNFGIVTRFWMRSPGASGTDPAGLLPRPPASLLTAMVNWTWEQCELPAFTRIVRNFMGWHVANSAPGSPSAGLFASLWVRHRSGGGLTMFVQADATEPDAAAGLDAFLAAVDEGVGVTPFVHRRELPWLTASRYMGQGDSGPVMGARIKTKAAYLRDVHTDEQIATLYRWFHREDYFGRESLMMLNGYGGAINAVGPADTASVQRDSVIKAAYSASWGDPEEDETHLTWLRGLYGELYAGTGGVPVPGGPTDGSYINYPDIDLADPDHNRSGVPWHQLYYKDNYATLQAVKAAWDPRDVFHHALSVRLPEDDMTYPTAHIPEHYDFRAIYAGEKDASPVQPWDIGRPQPALVAAHDAGEITGDVLDVGCGLGDNAAFLAGRGHRVTAVDVAEAAVREARRRAEDSGVDVEFAVADATRLTGYDGRFDTVVDSACFHSLSEDERERYLRALRTATRPGGRLHMFCFAQEFEAPFPGPHRHTAASLREMVGGVWNVLSVEAATFASSLGVEDIAALIESEYPDGDVDPARLDGLPLDEHGKATMPVWHVTAERRD	MNTNLKPKLQRFASATAFACPICQENLTLLETNFKCCNRHSFDLAKFGYVNLAPQIKQSANYNKENFQNRQQILEAGFYQAILDAVSDLLASSKTTTTILDIGCGEGFYSRKLQESHSEKTFYAFDISKDSVQIAAKSEPNWAVNWFVGDLARLPIKDANMDILLDIFSPANYGEFRRVLSKDGILIKVIPTENHLKEIRQRVQDQLTNKEYSNQDIKEHFQEHFTILSSQTASLTKTITAEQLQALLSMTPLLFHVDQSKIDWSQLTEITIEAEILVGKAF	269.86	gnl|BL_ORD_ID|2052|hsp_num:0	2274			177	807	tylosin; mycinamicin
BGC0000211.1|Chrysomycin_28 # 26423 # 27199 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.772	BGC0000211.1|Chrysomycin_28 	26423	27199	+	Loose	1200	30.4166	arnA	34.04	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGCGCGCCGTACGGCCGGACGTCGTCGTCAACGCCGCCGTGTTCACCGGCGTGGACCCCTGCGAGGCCGACCCGGCGCGCGCGTACGAGGTCAACGCCGTCGGCGCGCGCCATGTGGCGCGGGCCTGCGCCGACGTCGGCGCCCGCTGCGTCTACATCAGTACCGACTACGTCTTCGACGGCACCGCACCAGACCCCTACGACGAGACGGCACCGCCCCGCCCCCTGCTGACGTACGGCATGTCCAAGCTCGCCGGGGAGGGCGAGACCCTGAACGCGAGCCCCGGACACCTGGTGGTGCGCACCGCCGCTCTGTTCGGGCCGCCGCCGCCGAGCCACCGGCGCCGGCCGGGATTCGTCGAGCAGATCCTGCGCCGCGCGGCGGCCGGACAGCGCGCCGACGTGACCGACGCCCTGGTCATGTCCCCCACGTACACGGCCGACCTGGCCCGCATGGTCGTCGAACTGCTCGCCGCCGATGCGGACGGCGGGCCCTACCACGTGACCAACGAGGGCAGCGCCACCTGGTACGGCCTCGCGCACGCCGCCGTCTCCGGCCTGGGACTCGGCGCCCTGCCCCGGCAGGCCGCGCCCGGCGCCGGTGCGGCCGGTCCCGCGCGGCCCGCCGCCACGCCCCTGACCTCCGTGCGGCTGCCGCCGCGCGTGCGGCGGCTCAACCGCCCCTGGCGCGACGCCCTCGCGGAGTTCCTGCGCGACCACGGACCGGACGCCCTGGCCGCGGCCCGGCCCGGGCCTCCCCTTCCCGACGCCCCGTGA	MRAVRPDVVVNAAVFTGVDPCEADPARAYEVNAVGARHVARACADVGARCVYISTDYVFDGTAPDPYDETAPPRPLLTYGMSKLAGEGETLNASPGHLVVRTAALFGPPPPSHRRRPGFVEQILRRAAAGQRADVTDALVMSPTYTADLARMVVELLAADADGGPYHVTNEGSATWYGLAHAAVSGLGLGALPRQAAPGAGAAGPARPAATPLTSVRLPPRVRRLNRPWRDALAEFLRDHGPDALAAARPGPPLPDAP	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	38.97	gnl|BL_ORD_ID|1513|hsp_num:0	1643			1206	1344	polymyxin B
BGC0000211.1|Chrysomycin_30 # 28508 # 29446 # 1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=6bp;gc_cont=0.739	BGC0000211.1|Chrysomycin_30 	28508	29446	+	Loose	400	26.5646	ErmV	53.12	3002824	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGCCTGAGATGCGCTTCGTCGTCACGGGCTCCATCGCGACCGACCATCTGATGACCTTCCCCGGCCGTATCGGCGAACAGCTGATCGCCGGCAAGCTGGACCGCATCTCCCTCTCGCTGCTCGTCGACGACCTGGAGGTCCGGGACGGCGGTGTGGCCGCCAACATCGCCTACGGCCTGGCCCGGCTCGGTCACCGTCCGCTCCTCGTCGGGGCGGTCGGAACCGACTTCCACGACTACGGCGCCCGCCTGGCCGCCCTCGGGGTGGACACCTCGGCCGTCCGGGTCTCCACCACCCGGCACACGGCCCGCTTCCTGTGCACCACCGACACCGACGGCGGCCAGCTGGCCACCTTCTACGCCGGAGCGATGGCCGAGGCGTCCACGATCGACCTCGGCGACGTGCTGCGCCGCCACGGGGGCGCCGACCTCGTGCTGATCGGCGCCGACGACCCCACGGCGATGGCCCGCCACACCAGGGCCTGCCGCGCCCTCGGCGTCCCCTTCGCCGCAGACCCGGCGCAGCAACTGGCCCGGCTCACCGGCCCGGAGATCAGGGAACTGGTCGAGGGAGCGGACCATCTGTTCACCAACGAGTACGAGCGCGAGCTGCTGCTGGGCAAGACGGGCTGGACGCCGCAGGACGTGCTGCGCAGGACCGGCGTCTGGATCACCACGCTCGGCGACGAGGGCAGCCGCGTCGAGCGGGCCGGCGAACCTCCGGTGGGGGTCCCGGCCGTCCCGGCCCGCACGGTCGCCGACCCGACCGGAGTCGGTGACGCCTTCCGCGCCGGCTACCTGGCCTCCCTCGCGGCGGGCGCCGATGTGGAGCGGTGCGCACGGGCCGGGTCCGCTCTGGCCACCCTGGCGCTGTCGGCCGTCGGCACCCAGACGTACGTGCCCGCCCCCGCTCACCTCCACGAGCCGCCGCCGCGGTGA	MPEMRFVVTGSIATDHLMTFPGRIGEQLIAGKLDRISLSLLVDDLEVRDGGVAANIAYGLARLGHRPLLVGAVGTDFHDYGARLAALGVDTSAVRVSTTRHTARFLCTTDTDGGQLATFYAGAMAEASTIDLGDVLRRHGGADLVLIGADDPTAMARHTRACRALGVPFAADPAQQLARLTGPEIRELVEGADHLFTNEYERELLLGKTGWTPQDVLRRTGVWITTLGDEGSRVERAGEPPVGVPAVPARTVADPTGVGDAFRAGYLASLAAGADVERCARAGSALATLALSAVGTQTYVPAPAHLHEPPPR	MARPSRVSRALSQNFLADRAAAGQLARLAAPHGLPVPLLLEVGAGKGALTELLAPRCRSLLAYEIDPRLVPVLRSRFADAPHVRVLGEDFLRARAPRTPFSVAGNVPFSRTAAVVAWCLRAPHLTDATLLTQLEYARRRTGDYGSWTRLTVLTWPRHEWRLAGRVGRRSFRPVPRVDAGIVRIERRRTPLLAPGADAGWRELVDLGFSGAGGSLHASLRRARPRRRVDAAFRAAGLDRDVLVGEVPPWTWLRLHEVLGS	120.46	gnl|BL_ORD_ID|1095|hsp_num:0	1188			0	96	erythromycin; tylosin; oleandomycin; chalcomycin; kitasamycin; carbomycin; celesticetin
BGC0000211.1|Chrysomycin_14 # 11902 # 12819 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.742	BGC0000211.1|Chrysomycin_14 	11902	12819	+	Loose	210	27.7202	Escherichia coli AcrAB-TolC with MarR mutations conferring resistance to ciprofloxacin and tetracycline	33.33	3003378	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGACGCGCTCTGACCGAGCGGCGGCCGGACCTGCTCGACTCCCACTACCGGGTCGCGGACGAGGTGCTGGGGATCCCCCTGACACAGCTGTGCTGGAGGGGCCCGGCCGAGGAACTGCGGGCCATGCCCGTCACCCAGCCCGCCGTCTTCCTGACCAGCGTCGTCACCCATGAGGTGCTCGGCGGGCAGGGGGTCGTCCCCGACGTCGTGGCCGGACACAGCCTCGGCGAGTTCGCGGCGATGGTCACCGCGGGGGTGCTCGACTGGGTCGACGTCGTGCACCTGGTCCGGCTGCGGGGCCGGCTGATGGACGCGGTCAACCGCGAGATCCCGGGCAGCATGGGCGCGGTCATCGATGTCGAGTTGGGTGAACTGGAGGGCCTGTGCGCCCGGGCCGCCGCCGACACGGGCGAGATCGTCGAGATCGCCAACCACAACGACCACCGGCAGATCGTGGTCGCCGGGCAGACCGGCGGTGTGGCGCGCCTCCTCGAACTCGCCGAACGGGGCGGGGCCCAGCGGGTACTGACGCTCGACGTGGGCGGGTCGGCGCACTGCAGCCTCCTGTCCGGCATCGAGCCGGAGTTCCGGCGGGCGGTCGAGGCGCTCGACCTGCGCGATCCGGTCGTCCCCGTGATCTCGGCGGTGACGGCGGCCCCCGTCCGTACGGCCGCCGAGGCCGCCGACTGCCTGTCGCGGCAGTTCACCCACCGGGTGCGGTGGACGGAGACGGTGGAGGCGCTGACCGCGGCGGGCGTCGGCCGGTTCGTGGAGGTGGGGCCCGGCAGGACGCTGAGCAAGCTCTGCGGCCGGCTGGCCCCGGACGCGGAGACGTACCGGACCAACGACACCGAGCACGTCGACCGGGTGGCCGAGGCCCTCGGCACCGCGCGGCCGGCCCGGGCGCGGCTGTGA	MGRALTERRPDLLDSHYRVADEVLGIPLTQLCWRGPAEELRAMPVTQPAVFLTSVVTHEVLGGQGVVPDVVAGHSLGEFAAMVTAGVLDWVDVVHLVRLRGRLMDAVNREIPGSMGAVIDVELGELEGLCARAAADTGEIVEIANHNDHRQIVVAGQTGGVARLLELAERGGAQRVLTLDVGGSAHCSLLSGIEPEFRRAVEALDLRDPVVPVISAVTAAPVRTAAEAADCLSRQFTHRVRWTETVEALTAAGVGRFVEVGPGRTLSKLCGRLAPDAETYRTNDTEHVDRVAEALGTARPARARL	MKSTSDLFNEIIPLGRLIHMVNQKKDRLLNEYLSPLDITAAQFKVLCSIRCAACITPVELKKVLSVDLGALTRMLDRLVCKGWVERLPNPNDKRGVLVKLTTGGAAICEQCHQLVGQDLHQELTKNLTADEVATLEYLLKKVLP	211.81	gnl|BL_ORD_ID|1984|hsp_num:0	431			168	318	tigecycline; ciprofloxacin; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
